UnknownNot Applicable

Use of Infrared Photomodulation for Hormonal Balance (Joovvin' for Hormonal Health)

United States60 participantsStarted 2020-01-31

Plain-language summary

8-week pilot study looking at the impact of Joovv's infrared photo modulation product on male and female hormone levels.

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * United States resident Exclusion Criteria: * current Joovv or other photomodulation therapy user * under medical supervision for medically treatable illness * significant travel during study period * use of birth control

What they're measuring

Testosterone Change

Timeframe: baseline to week 8

change of thyroid-stimulating hormone (TSH)

Timeframe: baseline to week 8

Self report general wellness

Timeframe: baseline to week 8

Trial details

NCT IDNCT04245527

SponsorProofPilot

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2020-05-01

Contact for this trial

Matthew M Amsden

3232844626 crew@proofpilot.com

View on ClinicalTrials.gov More Testosterone Deficiency trials